Early research (Phase 1)Study completedNCT00343525What this trial is testingRepeat-Dose Study of Bavituximab in Patients With Chronic Hepatitis CWho this might be right forHepatitis C Peregrine Pharmaceuticals 24
Early research (Phase 1)Ended earlyNCT01554085What this trial is testingFirst in Human Study of ALS-002158; Single Dose, Food Effect in Healthy Volunteers; Multiple Doses in Chronic Hepatitis C Genotype 1Who this might be right forHepatitis C, Chronic Alios Biopharma Inc. 78
Testing effectiveness (Phase 2)Study completedNCT01726946What this trial is testingEvaluate the Safety and Efficacy of VX-135 With Ribavirin in Treatment-Naïve Subjects With Chronic Hepatitis CWho this might be right forChronic Hepatitis C Vertex Pharmaceuticals Incorporated 10
Early research (Phase 1)Study completedNCT03673696What this trial is testingThe Tolerability and Pharmacokinetics Study of HEC74647PA Capsule in Healthy Adult SubjectsWho this might be right forChronic Hepatitis c Sunshine Lake Pharma Co., Ltd. 105
Testing effectiveness (Phase 2)Study completedNCT01587586What this trial is testingDose Finding Study of Pegylated-P-Interferon-alpha-2b(P1101) in Treatment-Naive Subjects With Hepatitis C Virus Genotype 1 InfectionWho this might be right forHepatitis C, Chronic PharmaEssentia 107
Not applicableStudy completedNCT07702396What this trial is testingEfficacy of 12 Weeks Versus 24 Weeks Treatment of Directly Acting Antiviral Therapy in Patients With Hepatitis C Related Chronic Liver DiseaseWho this might be right forHeptatitis C Indus Hospital and Health Network 192
Large-scale testing (Phase 3)Study completedNCT01854697What this trial is testingEvaluate the Efficacy and Safety of Three Experimental Drugs Compared With Telaprevir (a Licensed Product) in People With Hepatitis C Virus Infection Who Have Not Had Treatment BeforeWho this might be right forChronic Hepatitis C Infection AbbVie 311
Not applicableWithdrawnNCT01691235What this trial is testingSIMpill Medication Dispensing Device in the Treatment of HCVWho this might be right forChronic Hepatitis C Virus University of Chicago
Post-approval studies (Phase 4)Study completedNCT00545233What this trial is testingPEGASYS (Peginterferon Alfa-2a (40KD)) Plus COPEGUS (Ribavirin) With or Without Pioglitazone in Treatment-Naive Patients With Chronic Hepatitis C and Insulin Resistance.Who this might be right forHepatitis C, Chronic Hoffmann-La Roche 155
Early research (Phase 1)Ended earlyNCT01586325What this trial is testingThe Safety, Tolerability, Pharmacokinetics, and Antiviral Activity of JNJ-47910382 at Different Doses and Dose Regimens in Asian Genotype-1, Chronic, HCV-Infected PatientsWho this might be right forChronic Hepatitis C Infection Janssen R&D Ireland 8
Very early researchStudy completedNCT03188276What this trial is testingThe Relationship Between MDSCs and NK Cells Activity of CHC Patient Treated by DAAsWho this might be right forChronic Hepatitis C Third Affiliated Hospital, Sun Yat-Sen University 52
Not applicableStudy completedNCT04330508What this trial is testingEffects of Direct-acting Antiviral Agents on HCV Cognitive Function, and Depression in HCV Related Cirrhosis: A Prospective Clinical TrialWho this might be right forDepression in Chronic Hepatitis C Post Graduate Institute of Medical Education and Research, Chandigarh 385
Large-scale testing (Phase 3)Study completedNCT00039871What this trial is testingPEG-Intron Plus Rebetol Treatment of Chronic Hepatitis C Subjects Who Failed Response to Alpha-Interferon Plus Ribavirin (Study P02370)Who this might be right forHepatitisHepatitis C, ChronicFibrosis+1 more Merck Sharp & Dohme LLC 2,333
Testing effectiveness (Phase 2)Study completedNCT00088504What this trial is testingMerimepodib (MMPD) in Triple Combination for the Treatment of Chronic Hepatitis CWho this might be right forHepatitis CHepatitis Vertex Pharmaceuticals Incorporated 315
Testing effectiveness (Phase 2)Study completedNCT01306617What this trial is testingEvaluate the Efficacy, Safety, and Pharmacokinetics of ABT-450 With Ritonavir (ABT-450/r) When Given Together With ABT-333 and Ribavirin (RBV) in Treatment-Naïve and Non-responder Subjects With Genotype 1 Chronic Hepatitis C Virus (HCV) InfectionWho this might be right forChronic Hepatitis C InfectionHepatitis CHepatitis C Virus AbbVie (prior sponsor, Abbott) 50
Testing effectiveness (Phase 2)Study completedNCT01795911What this trial is testingSafety Study of Pegylated Interferon Lambda Plus Single or 2 Direct Antiviral Agents With RibavirinWho this might be right forHepatitis C Bristol-Myers Squibb 165
Large-scale testing (Phase 3)Study completedNCT01704755What this trial is testingEvaluate the Safety and Efficacy of ABT-450/Ritonavir/ABT-267; (ABT-267 Also Known as Ombitasvir) and ABT-333 (Also Known as Dasabuvir) Coadministered With Ribavirin (RBV) in Hepatitis C Virus (HCV) Genotype 1-infected Adults With Compensated CirrhosisWho this might be right forChronic Hepatitis C InfectionCompensated Cirrhosis AbbVie (prior sponsor, Abbott) 381
Testing effectiveness (Phase 2)Study completedNCT00227435What this trial is testingDose Escalation Study to Evaluate the Safety and Antiviral Activity of Val-mCyd in Adults With Chronic Hepatitis CWho this might be right forChronic Hepatitis C Merck Sharp & Dohme LLC
Large-scale testing (Phase 3)Study completedNCT02673489What this trial is testingDaclatasvir and Sofosbuvir With Ribavirin in Subjects With Cirrhosis and Genotype 3 Hepatitis C InfectionWho this might be right forHepatitis C Bristol-Myers Squibb 106
Large-scale testing (Phase 3)Study completedNCT01903278What this trial is testingEfficacy and Safety Study of PEG-IFN-SA and Ribavirin to Treat Chronic Hepatitis CWho this might be right forChronic Hepatitis c Beijing Kawin Technology Share-Holding Co., Ltd. 719